Paul Hartmann AG

PHH2

Company Profile

  • Business description

    Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

  • Contact

    Paul-Hartmann-Strasse 12
    Heidenheim89522
    DEU

    T: +49 7321360

    http://www.hartmann.info

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    9,881

Stocks News & Analysis

stocks

ASX rare earths play looks to expand production

The largest rare-earth producer outside of China acquires competitor to increase production.
stocks

Anthropic’s leaked financials reflect fast growth, but not a $2 trillion valuation

Draft IPO filing shows a company growing faster than its annual results can capture.
stocks

The 10 best US companies to invest in now

The stocks of these high-quality companies look cheap today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,907.1047.900.54%
CAC 407,834.1063.09-0.80%
DAX 4025,254.2123.010.09%
Dow JONES (US)51,267.9090.940.18%
FTSE 10010,497.9435.990.34%
HKSE24,228.47188.130.78%
NASDAQ27,477.31286.451.05%
Nikkei 22570,502.42555.560.79%
NZX 50 Index13,700.121.100.01%
S&P 5007,773.9551.230.66%
S&P/ASX 2008,739.7053.300.61%
SSE Composite Index3,842.1911.740.31%

Market Movers